Bio Essence (BIOE) Non Operating Income (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Non Operating Income of -$583.0 in Q1 2026, down 7.96% quarter-over-quarter from -$540.0 in Q4 2025, and up 11.67% on a YoY basis from -$522.09 in Q1 2025.
Bio Essence (BIOE) Non Operating Income (2020 - 2026) Analysis & Trends
Bio Essence's Non Operating Income history runs 7 years deep, the most recent figure standing at -$583.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 11.67% year-over-year to -$583.0; the TTM figure through Mar 2026 stood at -$2937.0 (up 99.74% YoY), while the FY2025 annual figure was -$3014.0, up 99.73% from the prior year.
- Non Operating Income was -$583.0 for Q1 2026 at Bio Essence, down from -$540.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $28842.0 in Q1 2024 to a low of -$1.1 million in Q3 2024.
- Historically, Non Operating Income has averaged -$68846.3 across 5 years, with a median of -$660.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income slumped 36703.01% in 2023, then jumped 2214.77% in 2024.
- A 5-year view of Non Operating Income shows it stood at $4205.0 in 2022, then surged by 195.55% to $12428.0 in 2023, then tumbled by 352.78% to -$31415.0 in 2024, then jumped by 98.28% to -$540.0 in 2025, then declined by 7.96% to -$583.0 in 2026.
- The last three Non Operating Income figures came in at -$583.0 (Q1 2026), -$540.0 (Q4 2025), and -$1255.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | -583.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -583.00 |
| Dec 31, 2025 | -540.00 |
| Sep 30, 2025 | -1,255.00 |
| Jun 30, 2025 | -559.00 |
| Mar 31, 2025 | -660.00 |
| Dec 31, 2024 | -31,415.00 |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -49,865.00 |
| Mar 31, 2024 | 28,842.00 |
| Dec 31, 2023 | 12,428.00 |
| Sep 30, 2023 | -22,406.00 |
| Jun 30, 2023 | -48,682.00 |
| Mar 31, 2023 | 1,246.00 |
| Dec 31, 2022 | 4,205.00 |
| Sep 30, 2022 | -6,663.00 |
| Jun 30, 2022 | 133.00 |
| Mar 31, 2022 | -1,568.00 |
| Dec 31, 2021 | -1,997.00 |
| Sep 30, 2021 | -1,284.00 |
| Jun 30, 2021 | 87.00 |